BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu J, Wang J, He Z, Chen P, Jiang X, Chen Y, Liu X, Jiang J. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer. Cell Death Dis 2021;12:648. [PMID: 34168120 DOI: 10.1038/s41419-021-03921-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Bravo-vázquez LA, Frías-reid N, Ramos-delgado AG, Osorio-pérez SM, Zlotnik-chávez HR, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. Translational Oncology 2023;27:101579. [DOI: 10.1016/j.tranon.2022.101579] [Reference Citation Analysis]
2 Wang C, Wang Z, Zhao Y, Jia R. Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancer. BMC Gastroenterol 2022;22:495. [DOI: 10.1186/s12876-022-02535-z] [Reference Citation Analysis]
3 Aseervatham J. Interactions between 14-3-3 Proteins and Actin Cytoskeleton and Its Regulation by microRNAs and Long Non-Coding RNAs in Cancer. Endocrines 2022;3:665-702. [DOI: 10.3390/endocrines3040057] [Reference Citation Analysis]
4 Pan W, Chen KJ, Huang YC. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C. Anticancer Drugs 2022;33:913-22. [PMID: 36136991 DOI: 10.1097/CAD.0000000000001381] [Reference Citation Analysis]
5 Xu B, Wei Y, Liu F, Li L, Zhou S, Peng Y, Li B. Long noncoding RNA CERS6-AS1 modulates glucose metabolism and tumor progression in hepatocellular carcinoma by promoting the MDM2/p53 signaling pathway. Cell Death Discov 2022;8:348. [PMID: 35927226 DOI: 10.1038/s41420-022-01150-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li N, Zeng A, Wang Q, Chen M, Zhu S, Song L. Regulatory function of DNA methylation mediated lncRNAs in gastric cancer. Cancer Cell Int 2022;22:227. [PMID: 35810299 DOI: 10.1186/s12935-022-02648-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xu J, Xu J, Liu X, Jiang J. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. Cell Death Discov 2022;8:287. [PMID: 35697671 DOI: 10.1038/s41420-022-01061-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Chen P, Zeng Z, Wang J, Cao W, Song C, Lei S, Li Y, Ren Z. Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis. Cell Death Discov 2022;8:198. [PMID: 35418193 DOI: 10.1038/s41420-022-01008-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zheng T, Han W, Wang A, Wang Y. Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation. PeerJ 2022;10:e12802. [DOI: 10.7717/peerj.12802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Li Z, Liu X, Luo N, Pang Y, Hou Y, Jiang G. Long non-coding RNA CERS6-AS1 plays a prognostic role in promoting the progression of gastric cancer. Bioengineered 2021;12:12931-9. [PMID: 34852705 DOI: 10.1080/21655979.2021.2012620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lange M, Begolli R, Giakountis A. Non-Coding Variants in Cancer: Mechanistic Insights and Clinical Potential for Personalized Medicine. Noncoding RNA 2021;7:47. [PMID: 34449663 DOI: 10.3390/ncrna7030047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]